{
  "weekly_top_story": {
    "headline": "Congress Reaches Deal To Avoid Trump Cuts, Boost HHS Spending",
    "summary": "Congress finalized a bipartisan FY2026 appropriations package boosting HHS funding to $116.6 billion while including key healthcare extenders like PBM reforms, Hospital at Home extensions, and telehealth flexibilities, stabilizing federal health programs amid budget pressures.",
    "source": "KFF Health News",
    "importance": 5,
    "impact_to_me": 5,
    "category": "Policy",
    "url": "https://kffhealthnews.org/morning-briefing/wednesday-january-21-2026/"
  },
  "stories": [
    {
      "headline": "Medicaid Tries New Approach With Sickle Cell: Companies Get Paid Only if Costly Gene Therapies Work",
      "summary": "Medicaid is piloting outcomes-based payments for sickle cell gene therapies, a strategy from the Biden era continued under Trump that could save costs and expand access to expensive treatments as more emerge.",
      "source": "KFF Health News",
      "importance": 4,
      "impact_to_me": 4,
      "category": "Policy",
      "url": "https://kffhealthnews.org/morning-briefing/wednesday-january-21-2026/"
    },
    {
      "headline": "Holland & Knight Health Dose: January 21, 2026",
      "summary": "The White House released President Trump's 'Great Healthcare Plan' proposing ACA restructuring, expanded HSAs, drug pricing reforms like TrumpRx and PBM changes, alongside congressional PBM transparency and spread-pricing bans in new appropriations.",
      "source": "Holland & Knight",
      "importance": 4,
      "impact_to_me": 4,
      "category": "Policy",
      "url": "https://www.hklaw.com/en/insights/publications/2026/01/holland-knight-health-dose-january-21-2026"
    }
  ]
}